MentionFoxMODEL ONCOLOGY, LLC filed a Form D with the Securities and Exchange Commission on 2026-10-19.
MODEL ONCOLOGY, LLC filed a Form D notice of an exempt securities offering with the SEC on October 19, 2026. The filing reports $10.91M sold. Its industry group is Other Health Care. It names THOMAS HARPER, JR. (Executive Officer, Promoter), DAVID CHERNOW (Executive Officer, Director), ROBERT ORTENZIO (Director) (SEC Form D, October 19, 2026).
Sell to companies like MODEL ONCOLOGY, LLC? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-10-19 · the record
Pitching, partnering or investing alongside them? See who really runs and owns MODEL ONCOLOGY, LLC.
Free to see. No signup.
We'll show it in your MentionFox inbox when MODEL ONCOLOGY, LLC raises, hires or launches. No email unless you switch it on.
Watch MODEL ONCOLOGY, LLC →Get the full cited report on MODEL ONCOLOGY, LLC
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on MODEL ONCOLOGY, LLC: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for MODEL ONCOLOGY, LLC →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 866 filings in Other Health Care, totalled by week. The dot is this raise, $10.91M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Proceeds will be used for working capital, which may include normal compensation to executive officers.
Thomas Harper, Jr. is named as Executive Officer and Promoter on the Form D that MODEL ONCOLOGY, LLC filed with the SEC on 19 October 2026, one of 9 people that filing names.
David Chernow is named as Executive Officer and Director on the Form D that MODEL ONCOLOGY, LLC filed with the SEC on 19 October 2026, one of 9 people that filing names.
Robert Ortenzio is named as Director on the Form D that MODEL ONCOLOGY, LLC filed with the SEC on 19 October 2026, one of 9 people that filing names.
Martin Jackson is named as Director on the Form D that MODEL ONCOLOGY, LLC filed with the SEC on 19 October 2026, one of 9 people that filing names.
William Downey is named as Director on the Form D that MODEL ONCOLOGY, LLC filed with the SEC on 19 October 2026, one of 9 people that filing names.
Stanley Marks, Md is named as Director on the Form D that MODEL ONCOLOGY, LLC filed with the SEC on 19 October 2026, one of 9 people that filing names.
Max Buetow is named as Director on the Form D that MODEL ONCOLOGY, LLC filed with the SEC on 19 October 2026, one of 9 people that filing names.
On the filing as: Promoter.
Phillip Watts is named as Mr. Watts is no longer affiliated with the Issuer, but has served as a promoter within the past 5 years. on the Form D that MODEL ONCOLOGY, LLC filed with the SEC on 19 October 2026, one of 9 people that filing names.
On the filing as: Promoter.
Steven Cutler is named as Mr. Cutler is no longer affiliated with the Issuer, but has served as a promoter within the past 5 years. on the Form D that MODEL ONCOLOGY, LLC filed with the SEC on 19 October 2026, one of 9 people that filing names.
9 people named on the filing — 2 holding an executive role, 5 as directors only and 2 named in another capacity.
Named as of the 2026-10-19 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on MODEL ONCOLOGY, LLC: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on MODEL ONCOLOGY, LLC covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist MODEL ONCOLOGY, LLCYou get an alert in MentionFox the next time this company shows up.
If you're behind MODEL ONCOLOGY, LLC: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for MODEL ONCOLOGY, LLC. With no account yet, you sign up free and land on the result.
https://mentionfox.com/funding/model-oncology-llc-form-d-000005